Deutsche Bank AG Cuts Position in Stevanato Group S.p.A. $STVN

Key Points

• Deutsche Bank AG reduced its stake in Stevanato Group S.p.A. by 5.1%, now holding approximately $19.19 million in shares, which represent about 0.31% of the company.
• Various hedge funds increased their stakes in Stevanato Group, with notable growth from Wells Fargo & Company MN, which raised its holdings by 680.3%.
• Stevanato Group maintains a consensus rating of "Moderate Buy" by analysts, with a price target of €25.13 ($29.56) following upgrades from firms like Stephens and William Blair.

Deutsche Bank AG lessened its position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 5.1% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 939,654 shares of the company's stock after selling 50,007 shares during the period. Deutsche Bank AG owned approximately 0.31% of Stevanato Group worth $19,188,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Bessemer Group Inc. lifted its stake in shares of Stevanato Group by 14,623.3% in the 1st quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock worth $270,000 after acquiring an additional 13,161 shares during the period. Palisade Capital Management LP lifted its stake in shares of Stevanato Group by 52.0% in the 1st quarter. Palisade Capital Management LP now owns 91,431 shares of the company's stock worth $1,867,000 after acquiring an additional 31,283 shares during the period. D. E. Shaw & Co. Inc. acquired a new stake in shares of Stevanato Group in the 4th quarter worth $281,000. Envestnet Asset Management Inc. grew its stake in shares of Stevanato Group by 16.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company's stock worth $3,324,000 after purchasing an additional 23,545 shares during the period. Finally, Yarbrough Capital LLC acquired a new position in shares of Stevanato Group during the 1st quarter worth $329,000.

Stevanato Group Price Performance

NYSE:STVN traded down €0.02 ($0.02) during mid-day trading on Monday, hitting €22.60 ($26.59). 69,595 shares of the company's stock traded hands, compared to its average volume of 339,641. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79. The firm's 50 day simple moving average is €24.48 and its 200 day simple moving average is €22.47. Stevanato Group S.p.A. has a 1 year low of €17.12 ($20.14) and a 1 year high of €28.00 ($32.94). The company has a market cap of $6.84 billion, a PE ratio of 41.85, a price-to-earnings-growth ratio of 2.13 and a beta of 0.55.

Wall Street Analyst Weigh In

STVN has been the topic of a number of recent analyst reports. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of €25.13 ($29.56).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.